Companies: 10,795·Total market cap: $144.5T
Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy

FPHAFOTCHealthcare
$3.30
+$0.00(+0.00%)
Market Cap$209542410
P/E Ratio
52W High$3.3
52W Low$3.3
Overview

Faron Pharmaceuticals Oy (FPHAF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · FPHAF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-339.00fphaf eps ttm · fphaf earnings per shareEarnings history
PE Ratio (TTM)fphaf pe ratio ttm · fphaf price to earningsPE Ratio deep dive
Revenue (TTM)0.00fphaf revenue ttm · fphaf annual revenueFull revenue history
Dividend YieldNo Dividenddoes fphaf pay dividends · fphaf dividend yieldDividend history
Shares Outstanding88.5Mfphaf shares outstanding · fphaf floatShares outstanding history
Next EarningsTBAfphaf earnings date · fphaf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$0.00
202220232024
faron pharmaceuticals oy revenue · fphaf revenue 2024
FY 2024Net Income-$25920.00▲ +99.92% YoY
202220232024
faron pharmaceuticals oy net income · fphaf profit 2024
FY 2024EPS$-0.00▲ +99.91% YoY
202220232024
fphaf eps · faron pharmaceuticals oy earnings per share 2024
TTM:Revenue: $0.00Net Income: -$31.0MEPS: $-339.00View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y+0.00%

About Faron Pharmaceuticals Oy

CEOMarkku Tapani Jalkanen
IPO DateApr 28, 2020
Employees40
CountryFI
Websitefaron.com

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical firm dedicated to drug discovery and development. The company is advancing a pipeline of proprietary drug candidates that harness immune …

what is faron pharmaceuticals oy · fphaf stock overview · faron pharmaceuticals oy company profile · who is faron pharmaceuticals oy ceo · fphaf OTC · faron pharmaceuticals oy headquarters · faron pharmaceuticals oy business segments

About Stock Overview & Key Data

Faron Pharmaceuticals Oy (FPHAF) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 28, 2020. As of the latest trading session, FPHAF stock price is $3.30, with a market capitalization of $209.5M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.

In fiscal year 2024, Faron Pharmaceuticals Oy reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Faron Pharmaceuticals Oy (FPHAF) stock price is $3.30. The stock is traded on OTC under the ticker symbol FPHAF. The 52-week range is $3.30 – $3.30.

FPHAF stock priceFPHAF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice